LOS ANGELES, Aug. 9 /PRNewswire/ -- The leading biopharmaceutical company specialized in adult stem cell therapeutics, RNL BIO Co., Ltd, (Korean Stock Exchange, 003190, www.rnl.co.kr) announced on ...

SEOUL, South Korea, Feb. 8, 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to ...

SOSUA BAY, Dominican Republic, Sept. 21, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI) CEO, Armando Casciati, announced today that Dr. Keunmyoung David Lee, Ph.D. will complete ...

RNL BIO Co. Ltd., a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, announces the ...

Seoul-based RNL Bio said the clones of Bernann McKinney's dog Booger were born last week after being cloned in cooperation with a team of Seoul National University scientists who created the world's ...

GERMANTOWN, Md., May 2, 2013 /PRNewswire/ -- RNL BIO, a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic ...

A South Korean stem cell company, RNL Bio Inc., is considering expanding its operations to the United States by setting up a research and development facility at the Life Sciences and Technology Park ...

The CEOs of two American companies in the cloning field, BioArts International and Start Licensing, today independently announced their opposition to the unlicensed activity of a third company based ...

SEOUL, South Korea, May 20, 2013 /PRNewswire/ -- RNL BIO Co. Ltd., a stem cell biotechnology company dedicated to the commercialization of autologous cell therapyproducts for a variety of degenerative ...